-
1 . Periodical
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
- 저자
- by Lee, Jong Wook; Griffin, Morag; Kim, Jin Seok; Lee Lee, Lily Wong; Piatek, Caroline, et al.
- 소스
- The Lancet Haematology; December 2023, Vol. 10 Issue: 12 pe955-e965, 11p